494 related articles for article (PubMed ID: 28384840)
21. Pseudo-observations in survival analysis.
Andersen PK; Perme MP
Stat Methods Med Res; 2010 Feb; 19(1):71-99. PubMed ID: 19654170
[TBL] [Abstract][Full Text] [Related]
22. Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia.
Raida L; Tucek P; Faber E; Vondrakova J; Rusinakova Z; Skoumalova I; Hubacek J; Jarosova M; Katrincsakova B; Pikalova Z; Kurfurst P; Indrak K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Dec; 155(4):327-32. PubMed ID: 22336644
[TBL] [Abstract][Full Text] [Related]
23. A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
Zahler S; Bhatia M; Ricci A; Roy S; Morris E; Harrison L; van de Ven C; Fabricatore S; Wolownik K; Cooney-Qualter E; Baxter-Lowe LA; Luisi P; Militano O; Kletzel M; Cairo MS
Biol Blood Marrow Transplant; 2016 Apr; 22(4):698-704. PubMed ID: 26785332
[TBL] [Abstract][Full Text] [Related]
24. Doubly robust estimators of causal exposure effects with missing data in the outcome, exposure or a confounder.
Williamson EJ; Forbes A; Wolfe R
Stat Med; 2012 Dec; 31(30):4382-400. PubMed ID: 23086504
[TBL] [Abstract][Full Text] [Related]
25. Sharp nonparametric bounds and randomization inference for treatment effects on an ordinal outcome.
Chiba Y
Stat Med; 2017 Nov; 36(25):3966-3975. PubMed ID: 28703430
[TBL] [Abstract][Full Text] [Related]
26. Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in China.
Tong J; Xuan L; Sun Y; Huang D; Liu H; Zheng C; Zhu X; Tang B; Song K; Zhang X; Zhang L; Yao W; Lin D; Liu Q; Sun Z
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1541-1548. PubMed ID: 28499936
[TBL] [Abstract][Full Text] [Related]
27. Augmented and doubly robust G-estimation of causal effects under a Structural nested failure time model.
Mertens K; Vansteelandt S
Biometrics; 2018 Jun; 74(2):472-480. PubMed ID: 28742252
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
29. Does Cox analysis of a randomized survival study yield a causal treatment effect?
Aalen OO; Cook RJ; Røysland K
Lifetime Data Anal; 2015 Oct; 21(4):579-93. PubMed ID: 26100005
[TBL] [Abstract][Full Text] [Related]
30. Doubly robust estimation of attributable fractions in survival analysis.
Sjölander A; Vansteelandt S
Stat Methods Med Res; 2017 Apr; 26(2):948-969. PubMed ID: 25519888
[TBL] [Abstract][Full Text] [Related]
31. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
Geskus RB
Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
[TBL] [Abstract][Full Text] [Related]
32. Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies.
Schuler MS; Rose S
Am J Epidemiol; 2017 Jan; 185(1):65-73. PubMed ID: 27941068
[TBL] [Abstract][Full Text] [Related]
33. Clinical Relevance of Apheretic Graft Composition in Patients With Acute Myeloblastic Leukemia Who Received a Busulfan-Fludarabine-Antithymocyte Globulin Conditioning Regimen for Allogeneic Transplant.
Yeral M; Kasar M; Boga C; Kozanoglu I; Ozdogu H; Sariturk C
Exp Clin Transplant; 2015 Oct; 13(5):453-60. PubMed ID: 26103468
[TBL] [Abstract][Full Text] [Related]
34. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
Odondi L; McNamee R
Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
[TBL] [Abstract][Full Text] [Related]
35. An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference.
Alonso A; Van der Elst W; Molenberghs G; Buyse M; Burzykowski T
Biometrics; 2016 Sep; 72(3):669-77. PubMed ID: 26864244
[TBL] [Abstract][Full Text] [Related]
36. A sensitivity analysis approach for the causal hazard ratio in randomized and observational studies.
Axelrod R; Nevo D
Biometrics; 2023 Sep; 79(3):2743-2756. PubMed ID: 36385393
[TBL] [Abstract][Full Text] [Related]
37. Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT).
Poiré X; Labopin M; Cornelissen JJ; Volin L; Richard Espiga C; Veelken JH; Milpied N; Cahn JY; Yacoub-Agha I; van Imhoff GW; Michallet M; Michaux L; Nagler A; Mohty M
Am J Hematol; 2015 Aug; 90(8):719-24. PubMed ID: 26010466
[TBL] [Abstract][Full Text] [Related]
38. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.
Latimer NR; Abrams KR; Siebert U
BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
Hamad N; Shanavas M; Michelis FV; Uhm J; Gupta V; Seftel M; Kuruvilla J; Lipton JH; Messner HA; Kim DD
Am J Hematol; 2015 May; 90(5):392-9. PubMed ID: 25615933
[TBL] [Abstract][Full Text] [Related]
40. Adjusting for observational secondary treatments in estimating the effects of randomized treatments.
Zhang M; Wang Y
Biostatistics; 2013 Jul; 14(3):491-501. PubMed ID: 23349243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
